Quantification of hepatitis C virus in human liver and serum samples by using LightCycler reverse transcriptase PCR

Area of Science:

• Virology
• Molecular Biology
• Hepatology

Background:

• Hepatitis C virus (HCV) infection poses a significant global health burden.
• Accurate viral load quantification is crucial for monitoring treatment efficacy and disease progression.
• Existing methods for measuring HCV RNA in liver tissue can be complex or lack sensitivity.

Purpose of the Study:

• To develop and validate a highly sensitive, non-probe-based, real-time quantitative reverse transcriptase PCR assay.
• To measure viral load in both serum and liver samples from HCV-infected patients.
• To assess the correlation between serum and hepatic HCV RNA levels.

Main Methods:

• Development of a novel real-time quantitative reverse transcriptase PCR (RT-PCR) assay.
• Utilized synthetic RNA for linearity assessment across a broad range of HCV RNA concentrations.
• Collected and analyzed paired serum and liver biopsy samples from 15 patients with HCV infection.

Main Results:

• The developed RT-PCR assay demonstrated high sensitivity and linearity over a wide dynamic range of HCV RNA copy numbers.
• A strong positive correlation was observed between HCV viral load measurements in serum and liver tissue (r = 0.689, P = 0.004).
• Results indicate that serum viremia is a reliable indicator of the viral burden within the liver.

Conclusions:

• The novel real-time RT-PCR assay provides a sensitive and reliable method for quantifying HCV RNA in both serum and liver.
• Serum viral load measurements effectively reflect the extent of HCV replication in the liver.
• This assay can aid in the clinical management and research of hepatitis C virus infection.